Health Sciences Fund Financials
We strongly advise to harness Health Sciences fundamental analysis to find out if markets are presently mispricing the fund. Simply put this technique allows you to validate available fundamentals of Health Sciences as well as the relationship between them. We are able to interpolate and collect thirteen available reported financial drivers for Health Sciences, which can be compared to its competitors.
Health |
Please note that past performance is not an indicator of the future performance of Health Sciences, its manager's success, or the effectiveness of its strategy. The performance results shown here may have been adversely or favorably impacted by events and economic conditions that may not prevail in the future. Therefore, you must use caution to infer that these results indicate any fund, manager, or strategy's future performance. Investment returns and principal value will fluctuate so that investors' shares, when sold, may be worth more or less than their original cost.
Health Sciences Fund Summary
Health Sciences competes with Tekla Healthcare, Schwab Health, The Hartford, Invesco Global, and Deutsche Health. The fund normally invests at least 80 percent of its net assets in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences . Valic Company is traded on NASDAQ Exchange in the United States.Instrument | USA Mutual Fund View All |
Exchange | NMFQS Exchange |
ISIN | US91915R7567 |
Business Address | AIG Retirement I |
Mutual Fund Family | VALIC |
Mutual Fund Category | Health |
Benchmark | NYSE Composite |
Phone | 800 448 2542 |
Currency | USD - US Dollar |
Health Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Health Sciences's current stock value. Our valuation model uses many indicators to compare Health Sciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Health Sciences competition to find correlations between indicators driving Health Sciences's intrinsic value. More Info.Health Sciences Fund is rated third in price to earning among similar funds. It is rated fourth in price to book among similar funds fabricating about 0.13 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Health Sciences Fund is roughly 7.42 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Health Sciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Health Sciences' Mutual Fund. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Health Sciences' earnings, one of the primary drivers of an investment's value.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any mutual fund could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in Health Mutual Fund
If you are still planning to invest in Health Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Health Sciences' history and understand the potential risks before investing.
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |